MedPath
NMPA Approval

Infliximab for Injection

国药准字S20210025

July 12, 2021

Drug Information

注射用英夫利西单抗

类停

注射剂

100mg/瓶

生物制品

July 12, 2021

Company Information

Applicant Company

泰州市中国医药城口泰路西侧、陆家路东侧G79幢

Manufacturing Company

泰州市中国医药城口泰路西侧、陆家路东侧G79幢;泰州市中国医药城祥泰路288号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用英夫利西单抗 - NMPA 批准文号 | MedPath